Gone are the days when antidepressants were your only hope for dealing with your depression. And that’s excellent news for people living with treatment-resistant depression. Today, Stefany Wolfsohn, MD, offers her patients Spravato™, FDA-approved intranasal esketamine for treatment-resistant depression. To learn more, call the office in Camarillo, California, to schedule a consultation.
For most people with depression, regularly meeting with a psychotherapist and/or taking antidepressants relieves the symptoms of this mental health disorder. But people living with treatment-resistant depression aren’t so lucky. If you’ve tried and failed multiple medications for depression, psychotherapy, group therapy, lifestyle modifications, complementary medicine alternatives, transcranial magnetic stimulation (TMS), have received already or are contemplating electroconvulsive therapy (ECT) then you are most likely living with treatment-resistant depression.
There’s good news, though. The FDA recently approved a safe, highly effective option for treatment-resistant depression. And it’s available at Ventura Center for Advanced Therapeutics. It’s called Spravato.
Spravato is a nasal spray that introduces esketamine ( chemically similar to ketamine) into your body. When you take this nasal spray, the ketamine has the opportunity to go to work in your brain.
The ketamine in Spravato works differently than oral antidepressants, targeting the N-methyl-D-aspartate (NMDA) receptor in your brain. Studies link this receptor to major depressive disorder and show that stimulating it with ketamine can deliver rapid antidepressant effects.
Because it can cause mild dissociation, you take Spravato under Dr. Wolfsohn’s supervision. After you take your dose of Spravato, you stay at Ventura Center for Advanced Therapeutics for at least two hours so their dedicated team can monitor you. Their office is well-appointed for your comfort. Dr. Wolfsohn and her team have worked to create a nurturing environment, complete with aromatherapy and comfortable seating.
You won’t be able to operate heavy machinery for the rest of the day, so arrange a ride home after your treatment.
During the first month, you take Spravato twice a week. Most patients see marked improvement in their depressive symptoms within the first four weeks.
After the first month, you can space your Spravato treatments further apart (usually every 1-2 weeks) as needed to maintain your results. You work with Dr. Wolfsohn to develop a plan that works for you, helping you effectively eliminate your depressive symptoms.
Don’t let treatment-resistant depression keep you from your healthiest, happiest life. Get started with Spravato by calling Ventura Center for Advanced Therapeutics to schedule a consultation or use our request appointment tool.